0 Comments
0 Shares
620 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Lenalidomide Drug Market Is Anticipated to Witness High Growth Owing to Rising Prevalence of Multiple Myeloma CasesLenalidomide, sold under the brand name Revlimid among others, is an immunomodulatory drug widely used for the treatment of multiple myeloma and other various types of cancers. The medications helps in inhibiting the growth of cancer cells and boosting the immune system to fight against the disease. The rising prevalence of multiple myeloma around the world has been a key driver for increased...0 Comments 0 Shares 652 Views 0 Reviews
-
Lenalidomide Market Trends Forecast and Industry Analysis to 2034Lenalidomide Market Overview Lenalidomide is an immunomodulatory drug that is vital to the treatment of cancers including multiple myeloma and myelodysplastic syndromes. When taken orally, its precise mode of action is still mostly unclear, however it involves immune system alteration and anti-tumor properties. It is commonly used in combination therapy because it inhibits angiogenesis, which...0 Comments 0 Shares 590 Views 0 Reviews
-
A Cross-Regional Examination of Advances in the U.S., Europe, and ChinaAdvances in the U.S. In the United States, the approach to treating MDS has evolved through a combination of cutting-edge research, personalized medicine, and a focus on patient-centered care. 1. Personalized Risk Stratification One of the most significant advancements in the U.S. has been the development of risk stratification systems such as the International Prognostic Scoring System (IPSS)...0 Comments 0 Shares 465 Views 0 Reviews